Electromed CFO exercises options and sells shares
Electromed, Inc.’s Chief Financial Officer, Bradley M. Nagel, reported a combination of stock option exercises and share sales on June 4, 2026.
Rhea-AI Filing Summary
Electromed, Inc.’s Chief Financial Officer, Bradley M. Nagel, reported a combination of stock option exercises and share sales on June 4, 2026. He exercised options to acquire 9,601 shares of common stock at exercise prices of $10.71 and $10.25 per share, converting derivative awards into common shares.
On the same date, he sold a total of 11,801 common shares in open-market transactions, with weighted average sale prices of approximately $36.34 for 11,620 shares and $37.11 for 181 shares. After these exercises, he retained 2,633 options at an exercise price of $10.71 expiring on June 30, 2033 and 2,166 options at $10.25 expiring on November 10, 2033.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 4,334 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) | 5,267 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,334 | $10.25 | $44K |
| Exercise | Common Stock | 5,267 | $10.71 | $56K |
| Sale | Common Stock | 11,620 | $36.3355 | $422K |
| Sale | Common Stock | 181 | $37.114 | $7K |
Footnotes (3)
- F1. Reflects the weighted average price of 11,620 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $36.04 to $37.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2. Reflects the weighted average price of 181 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $37.055 to $37.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3. Scheduled to vest and become exercisable with respect to remaining shares on June 30, 2026.
Key Figures
Key Terms
open-market sale financial
Employee Stock Option (right to buy) financial
derivative security financial
weighted average price financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Electromed (ELMD) CFO Bradley Nagel report in this Form 4?
What stock options did the Electromed (ELMD) CFO exercise?
Does the Electromed (ELMD) CFO still hold stock options after these transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.